Boehringer Ingelheim Investor
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies.
Technology:
Cell-based gene therapy, Cell_Therapies, Pharma, Whole-Cell Antigens
Industry:
End-to-end Drug Development, Private, Whole-Cell Antigens
Headquarters:
Ingelheim Am Rhein, Rheinland-Pfalz, Germany
Zip:
NA
Founded Date:
1885-01-01
Employees Number:
10001+
Funding Status:
N/A
Investor Type:
Undisclosed
Investment Stage:
N/A
Number Of Exits:
2
Acquisitions Number:
NA
Investors Number:
NA
Estimated Revenue:
$1B to $10B
Register and Claim Ownership